Hill-Rom Holdings Inc (HRC) Earns “Buy” Rating from KeyCorp

KeyCorp reissued their buy rating on shares of Hill-Rom Holdings Inc (NYSE:HRC) in a research note published on Tuesday. They currently have a $82.00 price target on the medical technology company’s stock.

HRC has been the subject of several other reports. Cantor Fitzgerald set a $86.00 price target on Hill-Rom Holdings and gave the stock a hold rating in a research report on Friday, July 28th. Zacks Investment Research upgraded Hill-Rom Holdings from a sell rating to a hold rating in a research report on Monday, September 18th. BidaskClub lowered Hill-Rom Holdings from a strong-buy rating to a buy rating in a research report on Monday, July 24th. Morgan Stanley raised their price target on Hill-Rom Holdings from $85.00 to $90.00 and gave the stock an overweight rating in a research report on Friday, June 30th. Finally, Needham & Company LLC lowered their price target on Hill-Rom Holdings from $95.00 to $93.00 and set a buy rating for the company in a research report on Friday, July 28th. Three equities research analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. Hill-Rom Holdings currently has an average rating of Buy and an average target price of $86.83.

Hill-Rom Holdings (NYSE HRC) traded up 1.11% during trading on Tuesday, reaching $81.19. The company had a trading volume of 432,643 shares. The firm has a market capitalization of $5.35 billion, a price-to-earnings ratio of 47.31 and a beta of 1.19. The company’s 50-day moving average is $76.37 and its 200 day moving average is $76.46. Hill-Rom Holdings has a 52 week low of $50.50 and a 52 week high of $84.65.

Hill-Rom Holdings (NYSE:HRC) last released its quarterly earnings results on Friday, July 28th. The medical technology company reported $0.91 EPS for the quarter, topping the consensus estimate of $0.90 by $0.01. Hill-Rom Holdings had a return on equity of 19.99% and a net margin of 4.27%. The business had revenue of $689.10 million during the quarter, compared to analyst estimates of $695.50 million. During the same period last year, the business posted $0.81 earnings per share. The company’s quarterly revenue was up 5.1% on a year-over-year basis. Equities analysts anticipate that Hill-Rom Holdings will post $3.82 EPS for the current year.

ILLEGAL ACTIVITY NOTICE: “Hill-Rom Holdings Inc (HRC) Earns “Buy” Rating from KeyCorp” was reported by Markets Daily and is the sole property of of Markets Daily. If you are accessing this piece on another domain, it was illegally copied and reposted in violation of United States and international copyright law. The original version of this piece can be viewed at https://www.themarketsdaily.com/2017/10/21/hill-rom-holdings-inc-hrc-earns-buy-rating-from-keycorp.html.

In related news, SVP Andreas G. Frank sold 6,870 shares of Hill-Rom Holdings stock in a transaction on Thursday, September 14th. The stock was sold at an average price of $77.48, for a total value of $532,287.60. Following the completion of the transaction, the senior vice president now directly owns 16,701 shares in the company, valued at $1,293,993.48. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, SVP Andreas G. Frank sold 3,940 shares of Hill-Rom Holdings stock in a transaction on Wednesday, September 13th. The shares were sold at an average price of $77.84, for a total value of $306,689.60. Following the completion of the transaction, the senior vice president now owns 16,701 shares of the company’s stock, valued at $1,300,005.84. The disclosure for this sale can be found here. Company insiders own 2.20% of the company’s stock.

A number of institutional investors have recently bought and sold shares of the business. Teacher Retirement System of Texas raised its stake in Hill-Rom Holdings by 0.3% in the second quarter. Teacher Retirement System of Texas now owns 5,194 shares of the medical technology company’s stock valued at $413,000 after buying an additional 14 shares in the last quarter. Stifel Financial Corp raised its stake in Hill-Rom Holdings by 0.5% in the second quarter. Stifel Financial Corp now owns 4,379 shares of the medical technology company’s stock valued at $349,000 after buying an additional 23 shares in the last quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS raised its stake in Hill-Rom Holdings by 0.5% in the second quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 8,734 shares of the medical technology company’s stock valued at $695,000 after buying an additional 46 shares in the last quarter. Utah Retirement Systems raised its stake in Hill-Rom Holdings by 0.8% in the second quarter. Utah Retirement Systems now owns 12,013 shares of the medical technology company’s stock valued at $956,000 after buying an additional 100 shares in the last quarter. Finally, IFP Advisors Inc raised its stake in Hill-Rom Holdings by 3.0% in the second quarter. IFP Advisors Inc now owns 4,607 shares of the medical technology company’s stock valued at $367,000 after buying an additional 135 shares in the last quarter. Institutional investors own 82.31% of the company’s stock.

About Hill-Rom Holdings

Hill-Rom Holdings, Inc is a global medical technology company. The Company operates through four segments: North America Patient Support Systems, International Patient Support Systems, Front Line Care and Surgical Solutions. The Company’s products and services include Patient Support Systems, Front Line Care and Surgical Solutions.

Analyst Recommendations for Hill-Rom Holdings (NYSE:HRC)

Receive News & Ratings for Hill-Rom Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hill-Rom Holdings Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply